Jill DeSimone joins Swim Across America’s board of directors

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Clinical, real-world data reaffirming the long-term effectiveness of Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and Gardasil (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases will be presented at the EUROGIN International Multidisciplinary HPV Congress 2026 in Vienna, Austria, March 18-21.

March 20, 2026

Vol.52 No.11

In Brief

Mass General Brigham receives $50M gift for gene and cell therapy research

Mass General Brigham has received a $50 million gift for gene and cell therapy research. The gift, made by anonymous donors, will advance clinical research by experts at Mass General Brigham Cancer Institute and throughout the system, to deliver treatments for patients with cancer and other diseases.

March 13, 2026

Vol.52 No.10

Cancer Policy

House member introduces bill to increase funding for MCD testing of firefighters

Rep. Josh Gottheimer (D-NJ) introduced the FIRE Cancer Act on Feb. 27. The piece of legislation seeks to increase grant dollars available to local fire departments, specifically earmarked for cancer prevention, “including providing multi-cancer early detection testing or other forms of preventative tests.”

Five global teams awarded $125M to support cancer science research

Cancer Grand Challenges awards five global teams of scientists up to $25 million each to take on questions that could open entirely new routes for cancer prevention, detection, and treatment.

March 06, 2026

Vol.52 No.09

In Brief

Penn Medicine receives $10M to establish the King Center for Lynch Syndrome

Penn Medicine received a $10 million gift from Cynthia King, the late Jeffery King, and Jason and Julie Borrelli to establish the King Center for Lynch Syndrome, at the Abramson Cancer Center of the University of Pennsylvania.

March 06, 2026

Vol.52 No.09

Guest Editorial

California Institute of Regenerative Medicine and Cancer Research: A promise broken?

Approximately 21 years ago, I had the privilege of working and helping to pass Proposition 71, which authorized $3 billion dollars in state bonds to fund stem cell research in California.

February 20, 2026

Vol.52 No.07

By Stephen J. Forman